Exenatide Reduces Urinary Transforming Growth Factor-β1 and Type IV Collagen Excretion in Patients with Type 2 Diabetes and Microalbuminuria
Kidney and Blood Pressure Research, 06/08/2012
Exclusive author commentary
Zhang H et al. – The results indicate that exenatide reduces urinary transforming growth factor–β1 and type IV collagen excretion in patients with type 2 diabetes and microalbuminuria, which may be partly contributory to its directly renoprotective role.
Weiping Lu (06/09/2012) comments:
The article showed exenatide reduces urinary transforming growth factor–?1 and type IV collagen excretion in patients with type 2 diabetes and microalbuminuria, which may be partly contributory to its directly renoprotective role. The results is intresting. However, the sample size is small. therefore, further large sample studies are needed.



